OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoids and Mental Disorders
Tiziana Rubino, Erica Zamberletti, Daniela Parolaro
Handbook of experimental pharmacology (2015), pp. 261-283
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua, Kiran Vemuri, Mengchen Pu, et al.
Cell (2016) Vol. 167, Iss. 3, pp. 750-762.e14
Open Access | Times Cited: 617

Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review
Cecilia Sorensen, Kristen DeSanto, Laura M. Borgelt, et al.
Journal of Medical Toxicology (2016) Vol. 13, Iss. 1, pp. 71-87
Open Access | Times Cited: 313

Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice
Francesca Guida, Fabio Turco, Monica Iannotta, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 230-245
Closed Access | Times Cited: 292

The cannabinoid system and pain
Stephen G. Woodhams, Victoria Chapman, David P. Finn, et al.
Neuropharmacology (2017) Vol. 124, pp. 105-120
Open Access | Times Cited: 239

Cannabinoid CB1and CB2Receptor Signaling and Bias
Mikkel Søes Ibsen, Mark Connor, Michelle Glass
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 48-60
Open Access | Times Cited: 194

Lipids in psychiatric disorders and preventive medicine
Miriam Schneider, Beth Levant, Martin Reichel, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 336-362
Open Access | Times Cited: 151

The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
Erica Zamberletti, Marina Gabaglio, Daniela Parolaro
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1916-1916
Open Access | Times Cited: 104

How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Eva Hoch, Dominik Niemann, Rupert von Keller, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 87-105
Open Access | Times Cited: 103

Polyunsaturated fatty acids and endocannabinoids in health and disease
Hércules Rezende Freitas, Alinny Rosendo Isaac, Renato Malcher‐Lopes, et al.
Nutritional Neuroscience (2017) Vol. 21, Iss. 10, pp. 695-714
Closed Access | Times Cited: 100

Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 25
Open Access | Times Cited: 91

The endocannabinoid system in mental disorders: Evidence from human brain studies
Inés Ibarra‐Lecue, Fuencisla Pilar-Cuéllar, Carolina Muguruza, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 97-107
Open Access | Times Cited: 71

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
Claudio D’Addario, Vincenzo Micale, Martina Di Bartolomeo, et al.
Schizophrenia Research (2017) Vol. 188, pp. 132-140
Closed Access | Times Cited: 64

A systematic review of cannabidiol trials in neurodevelopmental disorders
Nina-Francecsa Parrella, Aron T. Hill, Peter G. Enticott, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 230, pp. 173607-173607
Open Access | Times Cited: 18

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
Anna Lisa Brigida, Stephen Schultz, Mariana Cascone, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 54

Cannabinoids as hippocampal network administrators
Carl R. Lupica, Yuhan Hu, Orrin Devinsky, et al.
Neuropharmacology (2017) Vol. 124, pp. 25-37
Closed Access | Times Cited: 51

Antinociceptive, anti-inflammatory, and cytotoxic properties of Origanum vulgare essential oil, rich with β-caryophyllene and β-caryophyllene oxide
Armenuhi Moghrovyan, Lilya Parseghyan, Gohar Sevoyan, et al.
The Korean journal of pain (2022) Vol. 35, Iss. 2, pp. 140-151
Open Access | Times Cited: 26

Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
Christina A. Brust, Matthew A. Swanson, Laura Bohn
Biochemical Society Transactions (2023) Vol. 51, Iss. 4, pp. 1533-1543
Open Access | Times Cited: 13

CB1 Receptor Signaling: Linking Neuroplasticity, Neuronal Types, and Mental Health Outcomes
Qianqian Gao, Muhammad Asim
Neurochemistry International (2025), pp. 105938-105938
Closed Access

Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Pablo Romero‐Sanchiz, Raquel Nogueira‐Arjona, Antoni Pastor, et al.
Neuropharmacology (2019) Vol. 149, pp. 212-220
Open Access | Times Cited: 42

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
María Scherma, Paolo Masia, Matteo Luca Deidda, et al.
Medicines (2018) Vol. 5, Iss. 4, pp. 107-107
Open Access | Times Cited: 39

Prospects for the Use of Cannabinoids in Psychiatric Disorders
Michał Graczyk, Małgorzata Łukowicz, Tomasz Dzierżanowski
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
Patrícia Soares Silva Montagner, Wesley Medeiros, Leandro Cruz Ramires da Silva, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 11

Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system
Erica Zamberletti, Fabiana Piscitelli, Valentina De Castro, et al.
Journal of Lipid Research (2016) Vol. 58, Iss. 2, pp. 301-316
Open Access | Times Cited: 35

The Epigenetics of Early Life Adversity: Current Limitations and Possible Solutions
Sarah Barnett Burns, Daniel Almeida, Gustavo Turecki
Progress in molecular biology and translational science (2018), pp. 343-425
Closed Access | Times Cited: 34

Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases
Amarendranath Choudhury, Tripti Sahu, Praveena L. Ramanujam, et al.
Neuropsychiatry (2018) Vol. 08, Iss. 01
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top